DFM Funding Monitor

To deliver the first medical treatment dedicated to patients with haemorrhagic strokebroad

OP2DRAIN · Horizon Europe grant · 2022-07-01–2024-06-30

EC contribution

€2,500,000

Total cost

€10,535,727

Beneficiaries

2

About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2021-ACCELERATOROPEN-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2021-ACCELERATOROPEN-01. CORDIS record →

Objective

The NANOp2lysis platform is a deep-tech technology to protect active enzymes by a reversible precipitation and to produce solid-state nanoparticles. Such particles can then be loaded at high concentration into tailored carrier (with specific targeting / slow delivery characteristics). O2L-001 (derived from NANOp2Lysis) is the first effective and safe treatment to remove intracerebral hematoma and reduce disability and death following acute hemorrhagic stroke (AHS). It has been tailored to be locally injected, after micro-invasive surgery, via a catheter at the core of the hematoma. The in vivo gelation of the product at body temperature allows a local and slow delivery of our new thrombolytic agent, OptPA. The main characteristics of O2L-001 are thus the following:-EASY. simplified model of administration (unique injection) -EFFICIENT. better thrombolytic effect on best translational model (vs gold standard)-SAFE. reduced side effect (bleeding and neurotoxoxicity vs gold standard)

Beneficiaries (2)

Organisation	Country	Role	EC contribution	SME
Op2Lysis	FR	coordinator	€2,500,000	Yes
OP2LYSIS DEVELOPMENT	BE	thirdParty	€0	Yes

Get the EU Defence Funding Calendar — free

The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.

Get the calendar

Yes — subscribe me to DFM Analysis, the free weekly briefing on European defence funding, and send me the monthly funding calendar. Unsubscribe anytime.

Website

We store your email to send the calendar and the weekly DFM Analysis briefing. Nothing else. Unsubscribe anytime.

Or browse all open defence & dual-use calls on the funding calendar →

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.